The report "Closed Systems Transfer Devices Market by Closing Mechanism (Color-to-Color Systems), Type (Needleless Systems), Component (Female Components, Male Luers), Technology (Air Cleaning/Filtration Devices), End User (Hospitals & Clinics) - Global Forecast to 2030", is projected to reach USD 2.09 billion by 2030 from USD 1.49 billion in 2025, at a CAGR of 7.0% during the forecast period.

Browse 273 market data Tables and 65 Figures spread through 289 Pages and in-depth TOC on "Closed Systems Transfer Devices Market by Closing Mechanism (Color-to-Color Systems), Type (Needleless Systems), Component (Female Components, Male Luers), Technology (Air Cleaning/Filtration Devices), End User (Hospitals & Clinics) - Global Forecast to 2030"

Download PDF-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=251802928

The cardiovascular devices market is growth-driven by a few factors, which include the high prevalence of cardiovascular diseases, increased preference for minimally invasive procedures, and advancement in medical technology. Cardiovascular diseases are one of the leading causes of deaths worldwide, monitoring and  and interventional devices are, are highly in demand.

The growing number of chronic conditions such as cancer, increasing attention on occupational safety, rising awareness regarding the advantages of closed system transfer devices (CSTDs), technological innovations, and increased regulatory adherence are likely to drive market growth. The high cost of integrating CSTDs, limited compatibility with specific medications or drug delivery systems, and limited reimbursement restrain the utilization of CSTDs, consequently retarding the adoption of these products in hospitals and oncology centers to some extent.

The membrane-to-membrane systems segment will hold the highest market share in the closed system transfer devices market, by type.

By type, the closed system transfer devices market is categorized into membrane-to-membrane systems and needleless systems. In 2023, the membrane-to-membrane systems segment held the largest share, by type. The high share and fast growth of this segment are due to their ease of use and lower rate of contamination with double-membrane containment systems. Membrane-to-membrane systems offer higher safety by forming a fully isolated environment during drug transfer.

The diaphragm-based devices segment held the highest revenue share of the closed system transfer devices market in 2024.

Based on technology, the closed system transfer devices market is bifurcated into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. In 2023, the share of the diaphragm-based devices segment was the highest at 43.0%. Diaphragm-based devices tend to be compatible with a wide variety of drug delivery systems and container closures, making them versatile for different clinical uses. They offer flexibility for handling hazardous drugs.

In 2024, North America accounted for the largest share of the closed system transfer devices market.

North America held the largest market share of the closed system transfer devices market in 2024 due to the ongoing research & development of innovative CSTD technologies and better safety, efficiency, and user experience. Additionally, tight regulations over handling hazardous drugs within healthcare environments necessitate the employment of CSTDs to ensure that there is reduced risk exposure to hazardous drugs. Enforcement of these regulations spurs the use of CSTDs within the region.

Key Market Players

The key players in the global closed system transfer devices market include BD (US), ICU Medical, Inc. (US), EQUASHIELD (US), Corning Incorporated (US), Simplivia Healthcare Ltd. (Israel), JMS (Japan), Baxter (US), Terumo Corporation (Japan), Cardinal Health (US), B Braun Melsungen AG (Germany), West Pharmaceuticals Services, Inc. (US), CODAN Medizinische Geräte GmbH (Germany), Yukon Medical (US),  and INSUNG MEDICAL Co., Ltd. (South Korea).

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.